Latest news from Baylor College of Medicine

Mesothelioma Treatment Center opens study of new treatmentDec 20, 2016
The Mesothelioma Treatment Center has begun enrolling patients in a clinical research study for patients with malignant pleural mesothelioma.
Mouse models indicate burning more fat and less glucose could lead to diabetesDec 19, 2016
While exercise endurance increases when muscles are made to burn more fat and less glucose, research shows this may lead to diabetes.
Quick test helps identify frailty in bedbound elderlyDec 15, 2016
For older adults who are hospitalized for ground-level falls, their level of frailty can be an important indicator of adverse health outcomes upon discharge. 
For children with autism, the holidays take planning and communicationDec 15, 2016
Keys to success during the holiday season for families of children with autism spectrum disorder are advance communication and planning.
Adult children should pay closer attention to elderly parents during holiday visits Dec 14, 2016
The holidays are a practical time to check on mom and dad’s health and perhaps schedule much needed doctor appointments, according to Dr. Robert Roush, professor of medicine-geriatrics.
Dr. Matzuk elected to the National Academy of InventorsDec 14, 2016
Dr. Martin M. Matzuk has been awarded the distinction of Fellow in the National Academy of Inventors for his contributions to reproductive medicine and therapeutics.
Safety precautions before you take the ice this winterDec 13, 2016
Dr. Theodore Shybut shares ways to stay safe while enjoying ice skating during the holiday season.
Expert offers tips on coping with divorce during the holidays Dec 12, 2016
Dr. James Bray offers his tips on how to cope with divorce so families can enjoy the holidays.
Scalp-cooling device cuts hair loss in breast cancer patients undergoing chemotherapyDec 9, 2016
A scalp cooling cap has been shown to effective in reducing hair loss in breast cancer patients undergoing chemotherapy.
Promising results shown from combination therapy in HER2-positive and hormone receptor-positive metastatic or local advanced breast cancerDec 8, 2016
A new study reveals the efficacy and safety of treating HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer with pertuzumab in combination with trastuzumab, along with an aromatase inhibitor.